Skip to Content
Biotechnology

A brain-controlled exoskeleton has let a paralyzed man walk in the lab

October 4, 2019
Man in exosketeton
Man in exosketetonFonds de Donation Clinatec

The news: A paralyzed man has walked again thanks to a brain-controlled exoskeleton suit. Within the safety of a lab setting, he was also able to control the suit’s arms and hands, using two sensors on his brain. The patient was a man from Lyon named Thibault, who fell 40 feet (12 meters) from a balcony four years ago, leaving him paralyzed from the shoulders down.  

How it worked: Thibault had surgery to place two implants, each containing 64 electrodes, on the parts of the brain that control movement. Software then translated the brain waves read by these implants into instructions for movement. The development of the exoskeleton, by Clinatec and the University of Grenoble, is described in a paper in The Lancet this week.

Herculean effort: Thibault trained for months, using his brain signals to control a video game avatar in order to hone the skills required to operate exoskeleton, which was held up by a ceiling-mounted harness. He was able to walk slowly in the suit and then stop, as he chose.

The future: The hope is that one day similar technology could eventually let people in wheelchairs move them using their minds. It’s an impressive breakthrough, but the device is many years away from being publicly available. For example, researchers need to find a way to get the suit to safely balance itself before it can be used outside the laboratory.

Sign up here for our daily newsletter The Download to get your dose of the latest must-read news from the world of emerging tech.

Deep Dive

Biotechnology

Sam Altman invested $180 million into a company trying to delay death

Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.

Forget designer babies. Here’s how CRISPR is really changing lives

The gene-editing tool is being tested in people, and the first treatment could be approved this year.

More than 200 people have been treated with experimental CRISPR therapies

But at a global genome-editing summit, exciting trial results were tempered by safety and ethical concerns.

Three-parent baby technique could create babies at risk of severe disease

The approach was designed to prevent mitochondrial disease, but new evidence shows it might not work as planned.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.